MedPath

Middle ear implantation surgery

Not Applicable
Recruiting
Conditions
Conductive hearing loss and mixed hearing loss
Registration Number
JPRN-UMIN000005153
Lead Sponsor
Shinshu University hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1
Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria are as follows: (1) Retrolabyrinthine deafness, central deafness (2) Active stage of refractory otitis media (3) Acute progressive sensorineural hearing loss (4) Inner ear disorder becaouse of labyrinthitis in adulthood (5) Chronic or refractory vestibular disfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The therapeutic effects are evaluated at 5 month after the middle ear implantation surgery, using the free field speech recognition threshold test. In the speech recognition threshold test with quiet, marked recovery is defined as any recovery of the maximum speech recognition score (%) by speech recognition threshold test using 67S or 57S Japanese monosyyrable word table (Japan Audiological Society 1967, 1957).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath